Appropriateness of direct oral anticoagulant prescribing in older subjects with atrial fibrillation discharged from acute medical wards
Aims Knowledge on the prescriptive practice of direct oral anticoagulants (DOACs) in older subjects with atrial fibrillation (AF) hospitalized in acute medical wards is limited. This study aimed to evaluate the prevalence and appropriateness of DOAC prescriptions in hospitalized older subjects with...
Saved in:
Published in | British journal of clinical pharmacology Vol. 90; no. 5; pp. 1231 - 1239 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
01.05.2024
|
Subjects | |
Online Access | Get full text |
ISSN | 0306-5251 1365-2125 1365-2125 |
DOI | 10.1111/bcp.16010 |
Cover
Loading…
Abstract | Aims
Knowledge on the prescriptive practice of direct oral anticoagulants (DOACs) in older subjects with atrial fibrillation (AF) hospitalized in acute medical wards is limited. This study aimed to evaluate the prevalence and appropriateness of DOAC prescriptions in hospitalized older subjects with AF, discharged from acute medical wards.
Methods
We analysed a cohort of 609 subjects with AF, aged ≥65 years (mean age 85 years) enrolled from 39 geriatric and nephrology wards in Italy. DOAC prescriptive appropriateness was evaluated according to the summary of product characteristics (smPC), 2019 Beers and STOPP criteria, and drug–drug interactions (DDIs).
Results
At hospital discharge, 33% of patients with AF were prescribed with DOAC, 26% with vitamin‐K antagonist, while 41% did not receive any anticoagulant. Among subjects on DOAC therapy, 31% presented a violation of the smPC criteria (mainly underdosage—17%), while 48% and 18% presented a Beers/STOPP inappropriate prescription, or a DDI, respectively. Older age, lower body mass index (BMI), cancer and higher estimated glomerular filtration rate (eGFR) were independently associated with DOAC underdosage or missed prescription (age: adjusted odds ratio [aOR] 1.06, 95% confidence interval [95% CI] 1.00–1.12 for underdosage; eGFR: aOR 1.04, 95% CI 1.02–1.07 for underdosage; BMI: aOR 0.95, 95% CI 0.91–0.99 for missed prescription; cancer: aOR 1.93, 95% CI 1.19–3.13 for missed prescription).
Conclusions
This study showed a suboptimal DOAC prescriptive practice in older in‐patients, with frequent missed prescription and DOAC underdosage. Contrary to current recommendations, physicians appear overly concerned by bleeding risk in real‐life older and frailer subjects. Strategies should be developed to promote appropriate DOAC prescription in the hospital setting. |
---|---|
AbstractList | Aims
Knowledge on the prescriptive practice of direct oral anticoagulants (DOACs) in older subjects with atrial fibrillation (AF) hospitalized in acute medical wards is limited. This study aimed to evaluate the prevalence and appropriateness of DOAC prescriptions in hospitalized older subjects with AF, discharged from acute medical wards.
Methods
We analysed a cohort of 609 subjects with AF, aged ≥65 years (mean age 85 years) enrolled from 39 geriatric and nephrology wards in Italy. DOAC prescriptive appropriateness was evaluated according to the summary of product characteristics (smPC), 2019 Beers and STOPP criteria, and drug–drug interactions (DDIs).
Results
At hospital discharge, 33% of patients with AF were prescribed with DOAC, 26% with vitamin‐K antagonist, while 41% did not receive any anticoagulant. Among subjects on DOAC therapy, 31% presented a violation of the smPC criteria (mainly underdosage—17%), while 48% and 18% presented a Beers/STOPP inappropriate prescription, or a DDI, respectively. Older age, lower body mass index (BMI), cancer and higher estimated glomerular filtration rate (eGFR) were independently associated with DOAC underdosage or missed prescription (age: adjusted odds ratio [aOR] 1.06, 95% confidence interval [95% CI] 1.00–1.12 for underdosage; eGFR: aOR 1.04, 95% CI 1.02–1.07 for underdosage; BMI: aOR 0.95, 95% CI 0.91–0.99 for missed prescription; cancer: aOR 1.93, 95% CI 1.19–3.13 for missed prescription).
Conclusions
This study showed a suboptimal DOAC prescriptive practice in older in‐patients, with frequent missed prescription and DOAC underdosage. Contrary to current recommendations, physicians appear overly concerned by bleeding risk in real‐life older and frailer subjects. Strategies should be developed to promote appropriate DOAC prescription in the hospital setting. Knowledge on the prescriptive practice of direct oral anticoagulants (DOACs) in older subjects with atrial fibrillation (AF) hospitalized in acute medical wards is limited. This study aimed to evaluate the prevalence and appropriateness of DOAC prescriptions in hospitalized older subjects with AF, discharged from acute medical wards. We analysed a cohort of 609 subjects with AF, aged ≥65 years (mean age 85 years) enrolled from 39 geriatric and nephrology wards in Italy. DOAC prescriptive appropriateness was evaluated according to the summary of product characteristics (smPC), 2019 Beers and STOPP criteria, and drug-drug interactions (DDIs). At hospital discharge, 33% of patients with AF were prescribed with DOAC, 26% with vitamin-K antagonist, while 41% did not receive any anticoagulant. Among subjects on DOAC therapy, 31% presented a violation of the smPC criteria (mainly underdosage-17%), while 48% and 18% presented a Beers/STOPP inappropriate prescription, or a DDI, respectively. Older age, lower body mass index (BMI), cancer and higher estimated glomerular filtration rate (eGFR) were independently associated with DOAC underdosage or missed prescription (age: adjusted odds ratio [aOR] 1.06, 95% confidence interval [95% CI] 1.00-1.12 for underdosage; eGFR: aOR 1.04, 95% CI 1.02-1.07 for underdosage; BMI: aOR 0.95, 95% CI 0.91-0.99 for missed prescription; cancer: aOR 1.93, 95% CI 1.19-3.13 for missed prescription). This study showed a suboptimal DOAC prescriptive practice in older in-patients, with frequent missed prescription and DOAC underdosage. Contrary to current recommendations, physicians appear overly concerned by bleeding risk in real-life older and frailer subjects. Strategies should be developed to promote appropriate DOAC prescription in the hospital setting. Knowledge on the prescriptive practice of direct oral anticoagulants (DOACs) in older subjects with atrial fibrillation (AF) hospitalized in acute medical wards is limited. This study aimed to evaluate the prevalence and appropriateness of DOAC prescriptions in hospitalized older subjects with AF, discharged from acute medical wards.AIMSKnowledge on the prescriptive practice of direct oral anticoagulants (DOACs) in older subjects with atrial fibrillation (AF) hospitalized in acute medical wards is limited. This study aimed to evaluate the prevalence and appropriateness of DOAC prescriptions in hospitalized older subjects with AF, discharged from acute medical wards.We analysed a cohort of 609 subjects with AF, aged ≥65 years (mean age 85 years) enrolled from 39 geriatric and nephrology wards in Italy. DOAC prescriptive appropriateness was evaluated according to the summary of product characteristics (smPC), 2019 Beers and STOPP criteria, and drug-drug interactions (DDIs).METHODSWe analysed a cohort of 609 subjects with AF, aged ≥65 years (mean age 85 years) enrolled from 39 geriatric and nephrology wards in Italy. DOAC prescriptive appropriateness was evaluated according to the summary of product characteristics (smPC), 2019 Beers and STOPP criteria, and drug-drug interactions (DDIs).At hospital discharge, 33% of patients with AF were prescribed with DOAC, 26% with vitamin-K antagonist, while 41% did not receive any anticoagulant. Among subjects on DOAC therapy, 31% presented a violation of the smPC criteria (mainly underdosage-17%), while 48% and 18% presented a Beers/STOPP inappropriate prescription, or a DDI, respectively. Older age, lower body mass index (BMI), cancer and higher estimated glomerular filtration rate (eGFR) were independently associated with DOAC underdosage or missed prescription (age: adjusted odds ratio [aOR] 1.06, 95% confidence interval [95% CI] 1.00-1.12 for underdosage; eGFR: aOR 1.04, 95% CI 1.02-1.07 for underdosage; BMI: aOR 0.95, 95% CI 0.91-0.99 for missed prescription; cancer: aOR 1.93, 95% CI 1.19-3.13 for missed prescription).RESULTSAt hospital discharge, 33% of patients with AF were prescribed with DOAC, 26% with vitamin-K antagonist, while 41% did not receive any anticoagulant. Among subjects on DOAC therapy, 31% presented a violation of the smPC criteria (mainly underdosage-17%), while 48% and 18% presented a Beers/STOPP inappropriate prescription, or a DDI, respectively. Older age, lower body mass index (BMI), cancer and higher estimated glomerular filtration rate (eGFR) were independently associated with DOAC underdosage or missed prescription (age: adjusted odds ratio [aOR] 1.06, 95% confidence interval [95% CI] 1.00-1.12 for underdosage; eGFR: aOR 1.04, 95% CI 1.02-1.07 for underdosage; BMI: aOR 0.95, 95% CI 0.91-0.99 for missed prescription; cancer: aOR 1.93, 95% CI 1.19-3.13 for missed prescription).This study showed a suboptimal DOAC prescriptive practice in older in-patients, with frequent missed prescription and DOAC underdosage. Contrary to current recommendations, physicians appear overly concerned by bleeding risk in real-life older and frailer subjects. Strategies should be developed to promote appropriate DOAC prescription in the hospital setting.CONCLUSIONSThis study showed a suboptimal DOAC prescriptive practice in older in-patients, with frequent missed prescription and DOAC underdosage. Contrary to current recommendations, physicians appear overly concerned by bleeding risk in real-life older and frailer subjects. Strategies should be developed to promote appropriate DOAC prescription in the hospital setting. |
Author | Arena, Elena Aucella, Filippo Antonelli Incalzi, Raffaele Armentaro, Giuseppe De Vincentis, Antonio Sciacqua, Angela Aucella, Francesco Corsonello, Andrea Soraci, Luca |
Author_xml | – sequence: 1 givenname: Antonio orcidid: 0000-0003-0220-0500 surname: De Vincentis fullname: De Vincentis, Antonio email: a.devincentis@policlinicocampus.it organization: Università Campus Bio‐Medico di Roma – sequence: 2 givenname: Luca surname: Soraci fullname: Soraci, Luca organization: IRCCS INRCA – sequence: 3 givenname: Elena surname: Arena fullname: Arena, Elena organization: Università Campus Bio‐Medico di Roma – sequence: 4 givenname: Angela surname: Sciacqua fullname: Sciacqua, Angela organization: “Magna Graecia” University of Catanzaro – sequence: 5 givenname: Giuseppe surname: Armentaro fullname: Armentaro, Giuseppe organization: “Magna Graecia” University of Catanzaro – sequence: 6 givenname: Francesco surname: Aucella fullname: Aucella, Francesco organization: IRCCS “Casa Sollievo della Sofferenza” – sequence: 7 givenname: Andrea surname: Corsonello fullname: Corsonello, Andrea organization: IRCCS INRCA – sequence: 8 givenname: Filippo surname: Aucella fullname: Aucella, Filippo organization: IRCCS “Casa Sollievo della Sofferenza” – sequence: 9 givenname: Raffaele surname: Antonelli Incalzi fullname: Antonelli Incalzi, Raffaele organization: Università Campus Bio‐Medico di Roma |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38321367$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kUtPxCAUhYnR6PhY-AcMS11UeRSmXerEV2KiC103lF5GDFMq0Ez8Bf5tGUddmCgbbsh3Tw7n7KLN3veA0CElpzSfs1YPp1QSSjbQhHIpCkaZ2EQTwoksBBN0B-3G-EII5VSKbbTDK84yOJ2g9_NhCH4IViXoIUbsDe5sAJ2wD8ph1ServZqPLk94CBB1sK3t59j22LsOAo5j-5L5iJc2PWOVspbDxrbBOqeS9X0WjPpZhTl02AS_wEqPCfACOqszulShi_toyygX4eDr3kNPV5ePs5vi7v76dnZ-V2jOBCkUF7JcTa0ygmmjGVdVTWvJV08tMbVmVTkFqqtOcl1PSwGiVJWkJTWcVnwPHa91869fR4ipWWRzkJ324MfYsJrxlT6RGT36Qsc2e21ySAsV3prv8DJwsgZ08DEGMD8IJc2qmCYX03wWk9mzX6y26TOdFJR1_20srYO3v6Wbi9nDeuMD5KigOQ |
CitedBy_id | crossref_primary_10_7759_cureus_74526 crossref_primary_10_1007_s41999_024_01059_x |
Cites_doi | 10.7326/0003‐4819‐157‐7‐201210020‐00003 10.3389/fcvm.2022.1060096 10.1111/bcp.13631 10.1111/bcp.14029 10.1161/JAHA.119.014108 10.3390/pharmaceutics14071410 10.1007/s40266‐020‐00767‐w 10.3389/fphar.2018.01220 10.1001/archinte.159.7.677 10.1016/j.injury.2015.06.013 10.1111/jgs.15767 10.1080/07853890.2022.2117407 10.1093/europace/euab065 10.1161/CIRCULATIONAHA.110.004747 10.1161/CIRCULATIONAHA.113.005008 10.1016/j.arr.2011.03.003 10.1007/s11845‐018‐1837‐7 10.1093/europace/eux316 10.1016/j.ejim.2019.05.002 10.1186/s12877‐022‐03279‐x 10.3389/fphar.2022.996042 10.1093/ageing/afu145 10.2147/IJGM.S129235 |
ContentType | Journal Article |
Copyright | 2024 British Pharmacological Society. |
Copyright_xml | – notice: 2024 British Pharmacological Society. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1111/bcp.16010 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1365-2125 |
EndPage | 1239 |
ExternalDocumentID | 38321367 10_1111_bcp_16010 BCP16010 |
Genre | article Journal Article |
GeographicLocations | Italy |
GeographicLocations_xml | – name: Italy |
GroupedDBID | --- .3N .55 .GA .GJ .Y3 05W 0R~ 10A 1OC 23N 24P 2WC 31~ 33P 36B 3O- 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5VS 66C 6J9 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AAHQN AAIPD AAMNL AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABEML ABOCM ABPVW ABQWH ABXGK ACAHQ ACCFJ ACCZN ACFBH ACGFO ACGFS ACGOF ACMXC ACPOU ACSCC ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN ADZOD AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFPM AFGKR AFPWT AFWVQ AFZJQ AHBTC AIACR AIAGR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB AOIJS ATUGU AZBYB AZVAB BAFTC BAWUL BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DCZOG DIK DPXWK DR2 DRFUL DRMAN DRSTM DU5 E3Z EBS EJD EMOBN ESX EX3 F00 F01 F04 F5P FIJ FUBAC G-S G.N GODZA GX1 H.X HF~ HGLYW HYE HZI HZ~ IHE IPNFZ IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LSO LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OK1 OVD P2P P2W P2X P2Z P4B P4D Q.N Q11 QB0 R.K ROL RPM RX1 SUPJJ TEORI TR2 UB1 V8K W8V W99 WBKPD WHWMO WIH WIJ WIK WIN WOHZO WOW WQJ WRC WVDHM WXI WXSBR X7M XG1 YFH YOC YUY ZGI ZXP ZZTAW ~IA ~WT AAYXX AEYWJ AGHNM AGYGG CITATION AAMMB AEFGJ AGXDD AIDQK AIDYY CGR CUY CVF ECM EIF NPM 7X8 |
ID | FETCH-LOGICAL-c3250-a35643250baf52cfc23a89196350bab0f9c2847e1c8d63c9745e54a86141f3183 |
IEDL.DBID | DR2 |
ISSN | 0306-5251 1365-2125 |
IngestDate | Thu Jul 10 16:42:48 EDT 2025 Tue Sep 02 02:08:32 EDT 2025 Tue Jul 01 01:59:34 EDT 2025 Thu Apr 24 23:03:13 EDT 2025 Wed Jan 22 17:19:22 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Keywords | direct oral anticoagulants atrial fibrillation older inappropriate medications drug–drug interactions |
Language | English |
License | http://onlinelibrary.wiley.com/termsAndConditions#vor 2024 British Pharmacological Society. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3250-a35643250baf52cfc23a89196350bab0f9c2847e1c8d63c9745e54a86141f3183 |
Notes | The principal investigator for this paper is Prof. Raffaele Antonelli Incalzi and he had direct clinical responsibility for patients. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0003-0220-0500 |
PMID | 38321367 |
PQID | 2923325006 |
PQPubID | 23479 |
PageCount | 9 |
ParticipantIDs | proquest_miscellaneous_2923325006 pubmed_primary_38321367 crossref_primary_10_1111_bcp_16010 crossref_citationtrail_10_1111_bcp_16010 wiley_primary_10_1111_bcp_16010_BCP16010 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | May 2024 2024-05-00 20240501 |
PublicationDateYYYYMMDD | 2024-05-01 |
PublicationDate_xml | – month: 05 year: 2024 text: May 2024 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | British journal of clinical pharmacology |
PublicationTitleAlternate | Br J Clin Pharmacol |
PublicationYear | 2024 |
References | 2015; 46 2018; 9 2019; 2019 2021; 23 2012; 157 2019; 85 2019; 65 2017; 10 2015; 44 2022; 9 2020; 9 2022; 13 2020; 37 2022; 14 2011; 10 2018; 84 2022; 54 2022; 22 2014; 130 1999; 159 2018; 20 2019; 188 2011; 123 e_1_2_10_23_1 e_1_2_10_24_1 e_1_2_10_21_1 e_1_2_10_22_1 e_1_2_10_20_1 e_1_2_10_2_1 e_1_2_10_4_1 e_1_2_10_18_1 e_1_2_10_3_1 e_1_2_10_19_1 e_1_2_10_6_1 e_1_2_10_16_1 e_1_2_10_5_1 e_1_2_10_17_1 e_1_2_10_8_1 e_1_2_10_14_1 e_1_2_10_7_1 e_1_2_10_15_1 e_1_2_10_12_1 e_1_2_10_9_1 e_1_2_10_13_1 e_1_2_10_10_1 e_1_2_10_11_1 e_1_2_10_27_1 e_1_2_10_28_1 e_1_2_10_25_1 e_1_2_10_26_1 |
References_xml | – volume: 188 start-page: 101 issue: 1 year: 2019 end-page: 108 article-title: Is the prescription right? A review of non‐vitamin K antagonist anticoagulant (NOAC) prescriptions in patients with non‐valvular atrial fibrillation. Safe prescribing in atrial fibrillation and evaluation of non‐vitamin K oral anticoagulants in stroke prevention (SAFE‐NOACS) group publication-title: Ir J Med Sci – volume: 13 start-page: 13 year: 2022 article-title: A focus on CKD reporting and inappropriate prescribing among older patients discharged from geriatric and nephrology units throughout Italy: a nationwide multicenter retrospective cross‐sectional study publication-title: Front Pharmacol – volume: 130 start-page: 138 issue: 2 year: 2014 end-page: 146 article-title: Efficacy and safety of rivaroxaban compared with warfarin among elderly patients with nonvalvular atrial fibrillation in the Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF) publication-title: Circulation – volume: 54 start-page: 2411 issue: 1 year: 2022 end-page: 2419 article-title: The role of prognostic stratification on prescription of anticoagulants in older patients with atrial fibrillation: a multicenter, observational, prospective European study (EUROSAF) publication-title: Ann Med – volume: 159 start-page: 677 issue: 7 year: 1999 end-page: 685 article-title: Choosing antithrombotic therapy for elderly patients with atrial fibrillation who are at risk for falls publication-title: Arch Intern Med – volume: 85 start-page: 2134 issue: 9 year: 2019 end-page: 2142 article-title: Appropriateness of prescription of oral anticoagulant therapy in acutely hospitalized older people with atrial fibrillation. Secondary analysis of the SIM‐AF cluster randomized clinical trial publication-title: Br J Clin Pharmacol – volume: 2019 start-page: 674 issue: 67 year: 2019 end-page: 694 article-title: Updated AGS Beers Criteria® for potentially inappropriate medication use in older adults publication-title: J Am Geriatr Soc – volume: 10 start-page: 87 year: 2017 end-page: 94 article-title: Utilization and prescribing patterns of direct oral anticoagulants publication-title: Int J Gen Med – volume: 123 start-page: 2363 issue: 21 year: 2011 end-page: 2372 article-title: Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation publication-title: Circulation – volume: 157 start-page: 471 issue: 7 year: 2012 end-page: 481 article-title: Two novel equations to estimate kidney function in persons aged 70 years or older publication-title: Ann Intern Med – volume: 46 start-page: 1765 issue: 9 year: 2015 end-page: 1771 article-title: Injuries and outcomes associated with traumatic falls in the elderly population on oral anticoagulant therapy publication-title: Injury – volume: 22 start-page: 601 issue: 1 year: 2022 article-title: Prevalence and factors associated with polypharmacy: a systematic review and meta‐analysis publication-title: BMC Geriatr – volume: 65 start-page: 51 year: 2019 end-page: 57 article-title: Drug–drug interactions involving CYP3A4 and p‐glycoprotein in hospitalized elderly patients publication-title: Eur J Intern Med – volume: 9 issue: 6 year: 2020 article-title: Rates of potentially inappropriate dosing of direct‐acting oral anticoagulants and associations with geriatric conditions among older patients with atrial fibrillation: the SAGE‐AF study publication-title: J Am Heart Assoc – volume: 44 start-page: 213 issue: 2 year: 2015 end-page: 218 article-title: STOPP/START criteria for potentially inappropriate prescribing in older people: version 2 publication-title: Age Ageing – volume: 10 start-page: 430 issue: 4 year: 2011 end-page: 439 article-title: Aging with multimorbidity: a systematic review of the literature publication-title: Ageing Res Rev – volume: 14 start-page: 1410 issue: 7 year: 2022 article-title: Drug–drug interactions with oral anticoagulants as potentially inappropriate medications: prevalence and outcomes in elderly patients in primary care and hospital settings publication-title: Pharmaceutics – volume: 37 start-page: 585 issue: 8 year: 2020 end-page: 593 article-title: Potentially inappropriate medications, drug–drug interactions, and anticholinergic burden in elderly hospitalized patients: does an association exist with post‐discharge health outcomes? publication-title: Drugs Aging – volume: 9 year: 2018 article-title: Appropriateness of DOAC prescribing before and during hospital admission and analysis of determinants for inappropriate prescribing publication-title: Front Pharmacol – volume: 23 start-page: 1612 issue: 10 year: 2021 end-page: 1676 article-title: 2021 European Heart Rhythm Association practical guide on the use of non‐vitamin K antagonist oral anticoagulants in patients with atrial fibrillation publication-title: EP Europace – volume: 9 year: 2022 article-title: Atrial fibrillation: primary prevention, secondary prevention, and prevention of thromboembolic complications: part 2 publication-title: Front Cardiovasc Med – volume: 84 start-page: 2010 issue: 9 year: 2018 end-page: 2019 article-title: Appropriateness of oral anticoagulant therapy prescription and its associated factors in hospitalized older people with atrial fibrillation publication-title: Br J Clin Pharmacol – volume: 20 start-page: 1577 issue: 10 year: 2018 end-page: 1583 article-title: Inappropriate doses of direct oral anticoagulants in real‐world clinical practice: prevalence and associated factors. A subanalysis of the FANTASIIA Registry publication-title: EP Europace – ident: e_1_2_10_15_1 doi: 10.7326/0003‐4819‐157‐7‐201210020‐00003 – ident: e_1_2_10_26_1 doi: 10.3389/fcvm.2022.1060096 – ident: e_1_2_10_6_1 doi: 10.1111/bcp.13631 – ident: e_1_2_10_7_1 doi: 10.1111/bcp.14029 – ident: e_1_2_10_13_1 doi: 10.1161/JAHA.119.014108 – ident: e_1_2_10_12_1 doi: 10.3390/pharmaceutics14071410 – ident: e_1_2_10_4_1 doi: 10.1007/s40266‐020‐00767‐w – ident: e_1_2_10_8_1 doi: 10.3389/fphar.2018.01220 – ident: e_1_2_10_27_1 doi: 10.1001/archinte.159.7.677 – ident: e_1_2_10_28_1 doi: 10.1016/j.injury.2015.06.013 – ident: e_1_2_10_21_1 doi: 10.1111/jgs.15767 – ident: e_1_2_10_23_1 doi: 10.1080/07853890.2022.2117407 – ident: e_1_2_10_22_1 doi: 10.1093/europace/euab065 – ident: e_1_2_10_24_1 doi: 10.1161/CIRCULATIONAHA.110.004747 – ident: e_1_2_10_16_1 – ident: e_1_2_10_19_1 – ident: e_1_2_10_25_1 doi: 10.1161/CIRCULATIONAHA.113.005008 – ident: e_1_2_10_2_1 doi: 10.1016/j.arr.2011.03.003 – ident: e_1_2_10_11_1 doi: 10.1007/s11845‐018‐1837‐7 – ident: e_1_2_10_9_1 doi: 10.1093/europace/eux316 – ident: e_1_2_10_5_1 doi: 10.1016/j.ejim.2019.05.002 – ident: e_1_2_10_18_1 – ident: e_1_2_10_3_1 doi: 10.1186/s12877‐022‐03279‐x – ident: e_1_2_10_17_1 – ident: e_1_2_10_14_1 doi: 10.3389/fphar.2022.996042 – ident: e_1_2_10_20_1 doi: 10.1093/ageing/afu145 – ident: e_1_2_10_10_1 doi: 10.2147/IJGM.S129235 |
SSID | ssj0013165 |
Score | 2.4378836 |
Snippet | Aims
Knowledge on the prescriptive practice of direct oral anticoagulants (DOACs) in older subjects with atrial fibrillation (AF) hospitalized in acute medical... Knowledge on the prescriptive practice of direct oral anticoagulants (DOACs) in older subjects with atrial fibrillation (AF) hospitalized in acute medical... |
SourceID | proquest pubmed crossref wiley |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1231 |
SubjectTerms | Administration, Oral Age Factors Aged Aged, 80 and over Anticoagulants - administration & dosage Anticoagulants - adverse effects atrial fibrillation Atrial Fibrillation - drug therapy direct oral anticoagulants Drug Interactions drug–drug interactions Factor Xa Inhibitors - administration & dosage Factor Xa Inhibitors - adverse effects Factor Xa Inhibitors - therapeutic use Female Hospitalization - statistics & numerical data Humans inappropriate medications Inappropriate Prescribing - prevention & control Inappropriate Prescribing - statistics & numerical data Italy - epidemiology Male older Patient Discharge Practice Patterns, Physicians' - standards Practice Patterns, Physicians' - statistics & numerical data |
Title | Appropriateness of direct oral anticoagulant prescribing in older subjects with atrial fibrillation discharged from acute medical wards |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fbcp.16010 https://www.ncbi.nlm.nih.gov/pubmed/38321367 https://www.proquest.com/docview/2923325006 |
Volume | 90 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LSwMxEA7Fkxffj_piFCke3NJ9tVs8qSjFgxRpoQdhSbKJiHVb3N2D_gH_tjNJt7U-QLyFJRt2k3l8SWa-Yew4SjhafVwBGYqWE_hBy-Gi5TlChUlDoFQpZaJ8b5udfnAzCAcVdlbmwlh-iOmBG2mGsdek4Fxkn5RcyDEdjZj0KorVIkB0581uEFxTRpIgMW62QnfCKkRRPNM3533RN4A5j1eNw7leZvflp9o4k6d6kYu6fPvC4vjPf1lhSxMgCudWclZZRaVrrNa1TNavp9CbJWZlp1CD7ozj-nWdvZ8TF_kYpTc3xhJGGqx3BEr5B1wvFDFOde7THCjYFq0TbsIf4DGFEVUGh6wQdAaUAR0FAzflQ0BTBsLQxucBZQwTkZNKgLJggMsiV_Bsr5aAwn2zDda_vupddpxJTQdH-oi2HO6HiIGwJbgOPaml5_OoTWaAHomGbktymMqVUdL0Je52QhUGPEIU4WqyP5tsIR2laptBJIRU6GBF4spAy3Zbc7I_vg40ojDNq-ykXN1YTgjPqe7GMC43PjjtsZn2Kjuadh1blo-fOh2WIhKjDtLFCk_VqMhiD1Ey_VOjWWVbVnamw_hUCspvtvBrjAT8Pn58cdk1jZ2_d91lix6iLBuBuccW8pdC7SNKysWBUYcPGHEPxg |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9tAEB4heiiXAi1tA4VOK4R6wFH8ShyJS0iLQktRhILEpbJ217sVApwI2wf6B_q3mdmNk_KSKm6Wtbbs3Xl8OzszH8B2kgmy-rQCKpYdLwqjjidkJ_CkjrOWJKnS2mb5HrcHp9H3s_hsAfbqWhjXH2IWcGPNsPaaFZwD0v9ouVQTjo1wfdULZvRm_oKvJ8H8DMG3RJIMimm7FfvTvkKcxzN79K43egAx7yJW63IOluFX_bEu0-SiWZWyqf7c6-P43L9ZgVdTLIo9JzyrsKDz17AzdM2sb3ZxNK_NKnZxB4fzNtc3b-Bvj9uRT0iAS2svcWzQOUjkqn-kJSMpE0x1n5fI-bZkoGgf_hvPcxwzOTgWleQwUIEcDUZhGUTQcBHCpUvRQy4a5l5OOkMuhEGhqlLjlTtdQs74Ldbg9ODbqD_wprQOngoJcHkijAkG0ZUUJg6UUUEoki5bAr4lW6ar2GdqXyVZO1S04Yl1HImEgIRv2AS9hcV8nOv3gImUSpOPlZmvIqO6XSPYBIUmMgTEjGjAl3p5UzXtec7UG5dpvfehaU_ttDfg82zoxDX6eGzQp1pGUlJDPlsRuR5XRRoQUOZ_arUb8M4Jz-w1IbNBhe0OfY0Vgaffn-73h_Zi_f-HfoSXg9HPo_To8PjHBiwFBLpcQuYHWCyvK71JoKmUW1Y3bgH3LxPg |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bSxwxFD6IQulL1d5cL-1pEfHBWXauO4tPW9vFtiKLKPhQGJJMIqLOLs7Mg_4B_7bnJDu7rm2h9C0MmTCTnMuX5JzvAGynuSCrTyugYtn1ojDqekJ2A0_qOO9IkiqtbZTvcXJ4Fv04j88XYL_JhXH8ENMDN9YMa69Zwce5eaLkUo35aITTq5aihJSFEdFJMLtC8G0dScbEtNuK_QmtEIfxTF-dd0a_Icx5wGo9zmAZfjXf6gJNrtp1Jdvq_hmN43_-zAq8miBR7DvRWYUFXbyGnaGjsr7bw9NZZla5hzs4nJFc372Bhz6TkY9JfCtrLXFk0LlH5Jx_pAUjGRNc6L6okKNtyTzRLvwCLwsccWlwLGvJh0Al8lkwCls_BA2nIFy7AD3klGFmctI5choMClVXGm_c3RJyvG_5Fs4G304PDr1JUQdPhQS3PBHGBIKoJYWJA2VUEIq0x3aAH8mO6Sn2mNpXaZ6EirY7sY4jkRKM8A0boHewWIwKvQaYSqk0eViZ-yoyqtczgg1QaCJDMMyIFuw2q5upCeM5F964zpqdD017Zqe9BZ-nXceO5uNPnT41IpKREvLNiij0qC6zgGAy_1MnacF7JzvTYUKuBRUmXfoaKwF_Hz_7cjC0jfV_7_oRXgy_DrKj78c_N-BlQIjLRWNuwmJ1W-stQkyV_GA14xHS-xKY |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Appropriateness+of+direct+oral+anticoagulant+prescribing+in+older+subjects+with+atrial+fibrillation+discharged+from+acute+medical+wards&rft.jtitle=British+journal+of+clinical+pharmacology&rft.au=De+Vincentis%2C+Antonio&rft.au=Soraci%2C+Luca&rft.au=Arena%2C+Elena&rft.au=Sciacqua%2C+Angela&rft.date=2024-05-01&rft.eissn=1365-2125&rft.volume=90&rft.issue=5&rft.spage=1231&rft_id=info:doi/10.1111%2Fbcp.16010&rft_id=info%3Apmid%2F38321367&rft.externalDocID=38321367 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0306-5251&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0306-5251&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0306-5251&client=summon |